MKA031
MKA031 (compound 6y) is a non-competitive MIF inhibitor with an IC50 value of 1.7 μM. MKA031 (compound 6y) interferes with MIF/AIF interaction, MIF nuclear translocation, and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) -induced dependent cell death. MKA031 can be used in the study of chronic hepatitis C virus infection[1].
Product Specifications
CAS Number
2951012-00-1
UNSPSC
12352005
Target
Macrophage migration inhibitory factor (MIF)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/mka031.html
Purity
98.69
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NC1=CC=CC=C1)C2=CC=C(C=C2)N3N=NC(C(NCC4=CC=CS4)=O)=C3
Molecular Formula
C21H17N5O2S
Molecular Weight
403.46
References & Citations
[1]Chen D, et al. Allosteric Inhibitors of Macrophage Migration Inhibitory Factor (MIF) Interfere with Apoptosis-Inducing Factor (AIF) Co-Localization to Prevent Parthanatos. J Med Chem. 2023 Jul 13;66 (13) :8767-8781.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15203947 1 Vial
Lentiviral mouse Apof shRNA (UAS) - Lentiviral mouse Apof shRNA (UAS) plasmid
Sign In for Pricing
View Details 
MBS1111936-01 0.02 mg (E-Coli)
Recombinant Erwinia tasmaniensis Anthranilate phosphoribosyltransferase (trpD)
Sign In for Pricing
View Details MBS1111936-02 0.02 mg (Yeast)
Recombinant Erwinia tasmaniensis Anthranilate phosphoribosyltransferase (trpD)
Sign In for Pricing
View Details MBS1111936-03 0.1 mg (E-Coli)
Recombinant Erwinia tasmaniensis Anthranilate phosphoribosyltransferase (trpD)
Sign In for Pricing
View Details MBS1111936-04 0.1 mg (Yeast)
Recombinant Erwinia tasmaniensis Anthranilate phosphoribosyltransferase (trpD)
Sign In for Pricing
View Details